4/A//SEC Filing
STEINMAN LAWRENCE 4/A
Accession 0001213900-25-059798
CIK 0001690080other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 5:34 PM ET
Size
8.5 KB
Accession
0001213900-25-059798
Insider Transaction Report
Form 4/AAmended
STEINMAN LAWRENCE
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-06-17+110,000→ 110,000 totalExercise: $0.93Exp: 2035-06-17→ Common Stock (110,000 underlying) - Award
Common Stock
2025-06-17+44,959→ 112,493 total
Footnotes (3)
- [F1]Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan (the "Equity Plan").
- [F2]Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer.
- [F3]The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001132679
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 5:34 PM ET
- Size
- 8.5 KB